跳至主要内容
临床试验/NCT02052089
NCT02052089已完成不适用

Prospective Randomized Clinical and Radiologic Study for the Treatment of Lateral Epicondylosis; Comparison Among PRP (Platelet-Rich Plasma) , Prolotherapy, Physiotherapy and ESWT (Extracorporeal Shockwave Therapy)

CM Chungmu Hospital2 个研究点 分布在 1 个国家目标入组 231 人开始时间: 2009年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
231
试验地点
2
主要终点
DASH scoring system to measure the changes in the upper extremity function

研究概览

简要总结

The purpose of this study is to find the optimal treatment method for chronic lateral epicondylosis, and focused on the 'healing mechanism' and 'pain modulation' of degenerated tendon.The hypothesis is that there will be significant difference between treatment groups and control group (physiotherapy) and also there will be significant difference among treatment groups.

详细描述

231 patients were randomized using a Random Sequence Generator (Random.org) into 4 groups: Group A (physiotherapy as a control, n=58), Group B (ESWT, n=62), Group C (Prolotherapy, n=56) and Group D (PRP, n=55). In group A, patients were educated to do stretching and eccentric strengthening exercise of wrist extensor muscles. In group B patients were treated with 3 sessions of high-energy shock wave therapy ESWT (Evotron, Switech medical, Kreuzlingen, CH) in 2 weeks interval. Total energy flux density ranged from 0.1 to 0.14 mJ/mm2 (1500 impulses). Shockwave was targeted over lateral epicondyle where maximum tenderness was located. In group C, injection of 20% dextrose (3cc mixed with 0.3cc of lidocaine) to ECRB tendon was done under ultrasound guidance and in group D, 3 cc of PRP (Harvest SmartPReP 2 APC 30 Process Kit, Harvest Technologies, Plymouth, MA) was injected into ECRB tendon under ultrasound guidance. 22G needle was used for injection in group C and D. The primary outcome measure is DASH scoring system which is recorded on the initial, 3rd, 6th, 18th and 24th month. Secondary outcome measures were ultrasonography (measured on initial, 6th and 24th month) and SSS (Subjective Satisfaction Score) measured on initial and 24th month. After 24 months from the last procedure, all serial questionnaires and physician-filled-SSS sheets were gathered and analyzed by a one-way analysis of variance and Scheffe post-test. A value of p<0.01 was considered statistically significant.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 35 to 80 years of age
  • history of elbow pain in the region of the lateral epicondyle for more than 6 months
  • more than 3 months of treatment for lateral epicondylosis before enrollment in the study with no subjective improvement
  • pain on resisted extension of wrist
  • local tenderness to palpation at the lateral epicondyle
  • confirmed as lateral epicondylosis on ultrasound imaging

排除标准

  • history of steroid or botulinum injection(s) within 6 months before study enrollment
  • other elbow pathology including nerve compression, previous elbow fracture, limited elbow range of motion, abnormal simple radiographic findings, history of elbow surgery and inflammatory arthropathies
  • upper extremity pain or discomforts from shoulder or wrist or hand

结局指标

主要结局

DASH scoring system to measure the changes in the upper extremity function

时间窗: upon initial examination, 3-month follow-up, 6-month follow-up, 18-month follow-up, 24-month follow-up

The DASH is intended to measure how much difficulty a subject has when performing common functional tasks and activities. The DASH consists of a 30-item questionnaire with 5 response options for each item with a scale ranging from 0, which indicates "least disability," to 100, which indicates "most disability." It incorporates questions related to functional limitations, symptoms, and psychosocial problems. The DASH has been well validated and has a smaller standard error of measurement and a validity comparable to that of joint-specific measures. Based on our preliminary study, grand mean of DASH score was set to 26.05, and we decided that 8 points difference of DASH score will be the minimum detectable change.

次要结局

  • SSS (Subjective Satisfaction Score)(upon initial examination and on the 24th month)
  • ultrasonography to asses changes in tendon pathology(upon initial examination, 6th month and 24th month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sang-Hoon Lhee

Director of CM Chungmu Hospital

CM Chungmu Hospital

研究点 (2)

Loading locations...

相似试验